PF-04995274

DB12675InvestigationalSmall molecule

Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of...

Formula / weight: C₂₃H₃₂N₂O₆ · 432.517 g/mol (avg)
Code names: PF-04995274

Resolves to

Compound

UNIIXI179PG9LVCAS1331782-27-4ChEMBLCHEMBL2152922PubChem53354764

Structure

InChIKeyWLLOFQROROXOMO-GOSISDBHSA-NSMILESOC1(CN2CCC(COC3=NOC4=CC=CC(O[C@@H]5CCOC5)=C34)CC2)CCOCC1

Targets

Q13639HTR4

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with PF-04995274, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account